Re: Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven

✍ Scribed by Jack A. Schalken

• Book ID: 113611060
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 113 KB
• Volume: 54
• Category: Article
• ISSN: 0302-2838
• DOI: 10.1016/j.eururo.2008.08.043